Clinical Trial Update: Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of alirocumab co-administered with high-dose atorvastatin in patients with hypercholesterolemia; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-24